Pharmaceutical Industry in China Q2 2013 - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

Pharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges" provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 196 tables & figures within 142 pages. The Chinese biopharmaceutical market is presented as follows: By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS) By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A wealth of financial information is provided including: Company financials, sales & revenue figures historical to Q2 2013 China GDP, economic growth, export (bulk drug, formulations) figures India

Original Post Pharmaceutical Industry in China Q2 2013 - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges